|
|
| Research article summary (published 30 Jul 2006): |
The science of stimulant abuse.
Full Abstract
Stimulant medications, although classified by the US Drug Enforcement Agency as controlled with a Schedule IIa rating, are ubiquitous in our society because of their popularity as an effective treatment for childhood ADHD. The number of stimulant products available for practitioners has tripled in the last decade. Although stimulants' action on central dopamine systems can be reinforcing, especially when delivered via intraperitoneal or intravenous routes in laboratory animals, they are far less addicting when taken orally by children in the context of a medical treatment. Fortunately, the therapeutic stimulants, available orally, have different pharmacodynamic and pharmacokinetic properties than the illicit stimulants, methamphetamine and cocaine. The lack of intravenous forms of the therapeutic stimulants acts as a natural barrier and tends to prevent addiction. Furthermore, MPH produces dysphoria in school age children, further limiting its reinforcing properties. These pharmacokinetics and pharmacodynamics of methylphenidate and amphetamine treatments for ADHD thus are less addicting because of their delivery systems. Future products, employing novel methods that only allow the drug molecule to be available if ingested, should further increase the safety of these important therapeutic agents.
Author information
Author/s: Greenhill, Laurence L (LL);
Affiliation: New York State Psychiatric Institute, New York, NY 10032, USA. larrylgreenhill(-atsign-)cs.com
Journal and publication information
Publication Type: Journal Article; Review
Journal: Pediatric annals (Pediatr Ann), published in United States. (Language: eng)
Reference: 2006-Aug; vol 35 (issue 8) : pp 552-6
Dates: Created 2006/09/21; Completed 2006/12/07;
PMID: 16986449, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: a double-blind, randomized, cross-over trial.
26 Oct 2005 - Drugs used in the treatment of attention-deficit/hyperactivity disorder affect postsynaptic firing rate and oscillation without preferential dopamine autoreceptor action.
13 Feb 2001 - Has NICE got it right? An international perspective considering the case of Technology Appraisal No. 98 by the National Institute for Health and Clinical Excellence (NICE).
12 Feb 2008 - [Stimulant therapy in children]
30 Oct 1982 - Evaluation of risks associated with short- and long-term psychostimulant therapy for treatment of ADHD in children.
28 Feb 2004 - Stimulant drugs for severe hyperactivity in childhood.
29 Jun 2001 - Stimulant therapy in attention deficit/hyperactivity disorder.
29 Nov 2003 - Effects of methylphenidate on sensitivity to reinforcement in children diagnosed with attention deficit hyperactivity disorder: an application of the matching law.
30 Dec 1999 - Effects of methylphenidate on kinematic aspects of handwriting in hyperactive boys.
30 Jul 2001 - Methylphenidate versus dextroamphetamine in ADHD.
29 Apr 1999
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.